Quantum Biopharma (QNTM) Receivables - Other (2019 - 2026)
Quantum Biopharma (QNTM) reported Receivables - Other of $208524.0 for Q1 2026, down 47.05% on a YoY basis from $393843.0 in Q1 2025, and down 9.75% sequentially from $231053.0 in Q4 2025.
Quantum Biopharma (QNTM) Receivables - Other (2019 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 8 years of Receivables - Other data on file, last reported at $208524.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Other fell 47.05% year-over-year to $208524.0; the trailing twelve-month figure through Mar 2026 stood at $208524.0 (down 47.05% YoY), and the FY2025 full-year result was $231053.0, down 38.33% from the prior year.
- Receivables - Other slipped to $208524.0 in Q1 2026, from $231053.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $951503.0 in Q2 2022 to a low of $78300.0 in Q3 2025.
- A 5-year average of $335764.9 and a median of $324564.0 in 2022 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other soared 198.25% in 2022 and plunged 76.46% in 2024, its largest moves.
- Tracing QNTM's Receivables - Other over 5 years: stood at $374377.0 in 2022, then tumbled by 42.78% to $214210.0 in 2023, then jumped by 74.91% to $374678.0 in 2024, then tumbled by 38.33% to $231053.0 in 2025, then dropped by 9.75% to $208524.0 in 2026.
- Business Quant data shows QNTM's Receivables - Other at $208524.0 in Q1 2026, $231053.0 in Q4 2025, and $78300.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Quantum Biopharma | 2.61 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 208,524.00 |
| Mar 31, 2026 | 208,524.00 |
| Dec 31, 2025 | 231,053.00 |
| Dec 31, 2025 | 231,053.00 |
| Sep 30, 2025 | 78,300.00 |
| Sep 30, 2025 | 78,300.00 |
| Jun 30, 2025 | 193,198.00 |
| Jun 30, 2025 | 193,198.00 |
| Mar 31, 2025 | 393,843.00 |
| Mar 31, 2025 | 393,843.00 |
| Dec 31, 2024 | 374,678.00 |
| Dec 31, 2024 | 374,678.00 |
| Sep 30, 2024 | 104,204.00 |
| Sep 30, 2024 | 104,204.00 |
| Jun 30, 2024 | 86,868.00 |
| Jun 30, 2024 | 86,868.00 |
| Sep 30, 2023 | 214,210.00 |
| Sep 30, 2023 | 214,210.00 |
| Jun 30, 2023 | 369,024.00 |
| Jun 30, 2023 | 369,024.00 |